The legacy of the blue pill offers a complicated case study for investors eyeing drug companies. While initial sales were remarkable, recent patent expiration and the rise of generic versions have severely influenced https://tesssclb763959.bloguerosa.com/39722180/the-blue-pill-and-pharma-a-risky-stake